Delivery Order SPE2DB22D3401-SPE2DB26FT0HT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $47,058.07 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets in quantities of 500 units. This competitive award, issued on October 21, 2025, with an ultimate completion date of October 22, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of 500 tablets of Ondansetron HCL 4 mg at a ceiling value of $10,310.45. This is a firm fixed-price, non-set-aside competitive award with an ultimate completion date of September 23, 2025. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count) with a ceiling value of $12,047.30. This firm fixed-price delivery order, which will be completed by October 29, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $5,965.38 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages). This non-competitive, firm fixed-price delivery order was awarded on October 24, 2025, with an ultimate completion date of October 27, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a continuation of services under...
- The Defense Logistics Agency awarded a delivery order valued at $3,426.87 to AmerisourceBergen Drug Corp for Ondansetron HCL 8 mg tablets (30-count) on October 31, 2025, with completion targeted for November 3, 2025. The contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania—the place of performance for this award—is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at approximately $29,900 on September 23, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, reflecting the contractor's ability to compete in open procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,693.62 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 4 mg tablets (30-count) on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $3,554.96 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of July 15, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Ondansetron HCl 4 mg tablets (30-count units) valued at $3,824.84. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by July 25, 2025. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a small-value transaction executed under...
- The Defense Logistics Agency awarded a $20,050.94 delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30. The contract is classified as firm fixed price with no set-aside designation and is scheduled for ultimate completion by November 3, 2025. AmerisourceBergen will perform the delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB26FT0HTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Ondansetron HCL 4 mg tablets (30-count) with a contract value of $5,329.20. This competitive award, with no set-aside designation, is structured as a firm fixed price delivery order with an ultimate completion date of October 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999.99 billion prime vendor agreement valued through December 2026 that enables the supply of pharmaceuticals and medical commodities to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a critical federal vendor serving military and veteran healthcare systems through the Defense Logistics Agency. The company maintains an extensive portfolio of federal pharmaceutical supply contracts covering brand-name and generic medications, vaccines, medical devices, and specialized healthcare products across multiple therapeutic areas. As a prime contractor on the DLA Troop Support Medical contract, AmerisourceBergen demonstrates significant capability in meeting federal procurement requirements through open competition and maintains the flexibility to support diverse federal customers including the Defense Health Agency and U.S. Coast Guard through its comprehensive contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 10/28/25 |